Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today’s Visionaries in Cancer Immunotherapy Research
Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today’s Visionaries in Cancer Immunotherapy Research
Cancer Research Institute—The Cancer Research Institute recently announced its newest cohort of Scientists Taking Risks (STAR) funding for high risk/high reward research in tumor biology. Of the six recipients, three are core members of the Gladstone-UCSF Institute of Genomic Immunology: Kole Roybal, Ansuman Satpathy, and Matthew Spitzer.
Awards Gladstone Experts Genomic Immunology
